FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37534811000001107: Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Sep 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
365351000001114 Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
365361000001112 Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet Has AMP Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) true Inferred relationship Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet Is a Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet Has specific active ingredient Entacapone true Inferred relationship Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet Has specific active ingredient Carbidopa true Inferred relationship Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start